Ignite Creation Date:
2024-05-05 @ 5:20 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00438178
Status:
COMPLETED
Last Update Posted:
2014-05-12
First Post:
2007-02-21
Brief Title:
Safety and Efficacy of Obatoclax Mesylate GX15-070MS for the Treatment of Hematological Malignancies
Sponsor:
Gemin X
Organization:
Teva Branded Pharmaceutical Products RD Inc
Organization Data
Organization:
Teva Branded Pharmaceutical Products RD Inc
Class:
INDUSTRY
Study ID:
GX006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Gemin X
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Jean Viallet MD Chief Medical Officer
Old Organization:
Gemin X Pharmaceuticals